A trifluoromethyl quinoline derivative targets SGK1 and modulates the PI3K/AKT pathway to inhibit prostate cancer progression

Medical Oncology 2026

View at publisher

Authors: Xianhui Yang, Rui Wang, Guangcan Xu, Zhiqiang Yang, Xingsheng Yao, Guangyang Liu, Jia Yu, Bixue Xu, Heng Luo, Ying Cao

DOI: 10.1007/s12032-026-03256-z

Cited by: 0

Fields of Study & Subjects

PI3K/AKT/mTOR signaling in cancer Prostate Cancer Treatment and Research Cancer Mechanisms and Therapy